Newly established committee aims to develop Icon’s partnerships in the UK

Australian oncology provider Icon Group has established a European Board Committee as part of its bid to develop cutting edge collaborations with the NHS and UK independent healthcare sector. The move builds on Icon’s entry into the UK market via its acquisitions of Pharmaxo Group and Nuffield Health’s Cancer Centre London (CCL). The committee, an…